Commentary: Progressive multifocal leukoencephalopathy genetic risk variants for pharmacovigilance of immunosuppressant therapies by Joseph R. Berger, Hans-Peter Hartung, Hans-Peter Hartung, Hans-Peter Hartung

Get full text

Editorial: CNS autoimmune disorders and COVID-19 by Omid Mirmosayyeb, Shervin Badihian, Vahid Shaygannejad, Hans-Peter Hartung, Hans-Peter Hartung, Hans-Peter Hartung

Get full text

Bioavailable central nervous system disease-modifying therapies for multiple sclerosis by Hans-Peter Hartung, Hans-Peter Hartung, Hans-Peter Hartung, Hans-Peter Hartung, Bruce A.C. Cree, Michael Barnett, Sven G. Meuth, Amit Bar-Or, Lawrence Steinman

Get full text

Editorial: Immunosenescence and multiple sclerosis: Prognostic and therapeutic implications by Aurora Zanghì, Carlo Avolio, Carlo Avolio, Hans-Peter Hartung, Hans-Peter Hartung, Hans-Peter Hartung, Emanuele D'Amico

Get full text

Atacicept: targeting B cells in multiple sclerosis by Hans-Peter Hartung, Bernd C. Kieseier

Get full text

B cell targeted therapies in inflammatory autoimmune disease of the central nervous system by Moritz J. Furman, Sven G. Meuth, Philipp Albrecht, Philipp Albrecht, Michael Dietrich, Heike Blum, Jan Mares, Ron Milo, Hans-Peter Hartung, Hans-Peter Hartung, Hans-Peter Hartung

Get full text

The adenosinergic signaling in the pathogenesis and treatment of multiple sclerosis by Eduardo Duarte-Silva, Eduardo Duarte-Silva, Eduardo Duarte-Silva, Eduardo Duarte-Silva, Henning Ulrich, Ágatha Oliveira-Giacomelli, Hans-Peter Hartung, Hans-Peter Hartung, Hans-Peter Hartung, Hans-Peter Hartung, Sven G. Meuth, Christina Alves Peixoto, Christina Alves Peixoto

Get full text

Improvements in no evidence of disease activity with ublituximab vs. teriflunomide in the ULTIMATE phase 3 studies in relapsing multiple sclerosis by Enrique Alvarez, Lawrence Steinman, Edward J. Fox, Hans-Peter Hartung, Hans-Peter Hartung, Hans-Peter Hartung, Hans-Peter Hartung, Peiqing Qian, Sibyl Wray, Derrick Robertson, Krzysztof Selmaj, Krzysztof Selmaj, Daniel Wynn, Koby Mok, Yihuan Xu, Karthik Bodhinathan, Hari P. Miskin, Bruce A. C. Cree

Get full text

Prominent T-Cell Responses against the Acetylcholine Receptor ε Subunit in Myasthenia Gravis by Oliver Neuhaus, Karl-Heinz Wiesmüller, Hans-Peter Hartung, Heinz Wiendl

Get full text

Positive allosteric modulation of AMPA receptors via PF4778574 leads to reduced demyelination and clinical disability in experimental models of multiple sclerosis by Mustafa Sindi, Michael Dietrich, Diana Klees, Joel Gruchot, Christina Hecker, John Silbereis, Andrea Issberner, Hans-Peter Hartung, Hans-Peter Hartung, Hans-Peter Hartung, Tobias Ruck, Holger Stark, Thomas Kurz, Patrick Küry, Sven G. Meuth, Philipp Albrecht, Philipp Albrecht

Get full text

Using personalized prognosis in the treatment of relapsing multiple sclerosis: A practical guide by Bart Van Wijmeersch, Bart Van Wijmeersch, Bart Van Wijmeersch, Hans-Peter Hartung, Hans-Peter Hartung, Hans-Peter Hartung, Patrick Vermersch, Maura Pugliatti, Maura Pugliatti, Carlo Pozzilli, Nikolaos Grigoriadis, Mona Alkhawajah, Laura Airas, Ralf Linker, Celia Oreja-Guevara, Celia Oreja-Guevara

Get full text

Type O blood group associates with higher anti‐JC polyomavirus antibody levels by Pia Frenken, Hans‐Peter Hartung, Tomas Olsson, Ortwin Adams, Clemens Warnke

Get full text

Comparison of different optomotor response readouts for visual testing in experimental autoimmune encephalomyelitis-optic neuritis by Christina Hecker, Michael Dietrich, Andrea Issberner, Hans-Peter Hartung, Philipp Albrecht

Get full text

Age-dependent modulation of cortical transcriptomes in spinal cord injury and repair. by Anne Jaerve, Fabian Kruse, Katharina Malik, Hans-Peter Hartung, Hans Werner Müller

Get full text

Managing multiple sclerosis in individuals aged 55 and above: a comprehensive review by Óscar Fernández, Óscar Fernández, Per Soelberg Sörensen, Per Soelberg Sörensen, Giancarlo Comi, Giancarlo Comi, Patrick Vermersch, Hans-Peter Hartung, Hans-Peter Hartung, Hans-Peter Hartung, Letizia Leocani, Letizia Leocani, Thomas Berger, Thomas Berger, Bart Van Wijmeersch, Bart Van Wijmeersch, Celia Oreja-Guevara, Celia Oreja-Guevara

Get full text

Vaccine-based clinical protection against SARS-CoV-2 infection and the humoral immune response: A 1-year follow-up study of patients with multiple sclerosis receiving ocrelizumab by Saskia Räuber, Alice Willison, Melanie Korsen, Tristan Kölsche, Kristin S. Golombeck, Benedikt Plaack, Julia Schüller, Niklas Huntemann, Leoni Rolfes, Christina B. Schroeter, Christopher Nelke, Liesa Regner-Nelke, Moritz Förster, Marius Ringelstein, Marius Ringelstein, Michael Harry Barnett, Hans-Peter Hartung, Hans-Peter Hartung, Hans-Peter Hartung, Hans-Peter Hartung, Orhan Aktas, Philipp Albrecht, Tobias Ruck, Nico Melzer, Sven G. Meuth, David Kremer

Get full text

Downregulation of monocytic differentiation via modulation of CD147 by 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors. by Manda V Sasidhar, Sai Krishnaveni Chevooru, Oliver Eickelberg, Hans-Peter Hartung, Oliver Neuhaus

Get full text

Time for a standardized diagnostic response test in patients with chronic inflammatory demyelinating polyradiculoneuropathy? by Fabian Szepanowski, Benedikt Schoser, Anne K. Mausberg, Christoph Kleinschnitz, Hans‐Peter Hartung, Mark Stettner

Get full text

Outcome and Treatment Effects in Stroke Associated with Acute Cervical ICA Occlusion. by Michael Gliem, John-Ih Lee, Aurica Barckhan, Bernd Turowski, Hans-Peter Hartung, Sebastian Jander

Get full text

Merits and culprits of immunotherapies for neurological diseases in times of COVID-19 by Marc Pawlitzki, Uwe K. Zettl, Tobias Ruck, Leoni Rolfes, Hans-Peter Hartung, Sven G. Meuth

Get full text